The Association of British Clinical Diabetologists (ABCD) has updated our position statement on the use of sodium-glucose cotransporter-2 inhibitors in type 1 diabetes.
Umesh Dashora, Dipesh C Patel, Robert Gregory, Peter Winocour, Ketan Dhatariya, Dinesh Nagi
Abstract
Presentation by Dr Jackie Elliott, Sheffield
Part of the DTN-UK Flash Glucose Monitoring Education Programme
Presentation by Nicola Taylor, Dietitian, Derby
Part of the DTN-UK Flash Glucose Monitoring Education Programme
Presentation by Dr Emma Wilmot, Derby
Part of the DTN-UK Flash Glucose Monitoring Education Programme
Presentation by Dr Iain Cranston
Part of the DTN-UK Flash Glucose Monitoring Education Programme
I am pleased to share the entries which won Rowan Hillson Inpatient Safety Award this year.
You might find some of the ideas in these entries quite easy and useful to replicate in your institution.
Please e mail me at u.dashora@nhs.net if you need any further information.
Presentated at the 4th Joint Meeting of ABCD & The Renal Association on Wednesday, 13 February, 2019.
Intensive medical therapy is associated with increase urinary excretion of neutrophil gelatinase-associated lipocalin (ngal) in experimental diabetic nephropathy. Yeong Huei Desmond Chuah
Evaluation of HbA1c in a primary care cohort with Diabetes and Chronic Kidney disease (CKD). Anne Currie.
Presentated at the 4th Joint Meeting of ABCD & The Renal Association on Wednesday, 13 February, 2019 by Dr. Laurie Tomlinson, London School of Hygeine and Tropical Medicine.
Presentated at the 4th Joint Meeting of ABCD & The Renal Association on Wednesday, 13 February, 2019 by Dr. Richard Haynes, University of Oxford.
